AlphaYou
Overview
No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.
Key stats
Aug 21- 52-wk high
- $122.21
- 52-wk low
- $28.66
- Prev close
- $66.60
- Mkt cap
- $13.09B
- P/E
- 263.1x
- Fwd P/E
- 60.2x
Smart money
Earnings
Earnings came in $0.40 a share above what analysts expected.
Financials
What it sold, what it cost, what was left.
Sep 2025Dec 2025Mar 2026Jun 2026
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $207.6M | $202.1M | $164.9M | $256.1M |
| Cost of what it sold | $4.6M | $2.5M | $2.9M | $4.1M |
| Gross profit | $203.0M | $199.6M | $162.0M | $252.1M |
| What it spent | ||||
| Research and development | $68.8M | $64.9M | $66.3M | $53.9M |
| Sales and admin | $124.0M | $130.2M | $145.4M | $156.9M |
| Total operating expenses | $192.8M | $195.1M | $211.6M | $210.8M |
| What was left | ||||
| Operating profit | $10.2M | $4.5M | -$49.6M | $41.3M |
| Profit before tax | $15.2M | $9.9M | -$44.7M | $45.9M |
| Tax | -$4.4M | -$14.4M | -$13.5M | -$2.9M |
| Net profit | $19.7M | $24.3M | -$31.2M | $42.1M |
| EBITDA | $15.7M | $10.4M | -$44.1M | $46.8M |
Technicals
Price structure
No data yet
Technicals sync when verified market data is available. No sample data is shown.
News
What the news says
33 articles · 7 days
Coverage is bullish
Tone of tracked coverage
Truist Financial Initiates Corcept Therapeutics(CORT.US) With Buy Rating, Announces Target Price $164
BullishAug 19Corcept Therapeutics (NASDAQ:CORT) Director James Wilson Sells 10,000 Shares of Stock
NeutralAug 18Corcept (NASDAQ: CORT) director sells 10,000 shares under 10b5-1 plan
Leans bearish
